These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2344160)

  • 1. In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum.
    Kobayashi GS; Travis SJ; Rinaldi MG; Medoff G
    Antimicrob Agents Chemother; 1990 Apr; 34(4):524-8. PubMed ID: 2344160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatum.
    Kobayashi GS; Travis S; Medoff G
    Antimicrob Agents Chemother; 1986 Apr; 29(4):660-2. PubMed ID: 3010852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.
    Connolly P; Wheat J; Schnizlein-Bick C; Durkin M; Kohler S; Smedema M; Goldberg J; Brizendine E; Loebenberg D
    Antimicrob Agents Chemother; 1999 Feb; 43(2):322-8. PubMed ID: 9925526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of fluconazole and amphotericin B in treating histoplasmosis in immunosuppressed mice.
    Kobayashi GS; Travis SJ; Medoff G
    Antimicrob Agents Chemother; 1987 Dec; 31(12):2005-6. PubMed ID: 2830843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates.
    Brilhante RS; Fechine MA; Mesquita JR; Cordeiro RA; Rocha MF; Monteiro AJ; Lima RA; Caetano ÉP; Pereira JF; Castelo-Branco DS; Camargo ZP; Sidrim JJ
    Trans R Soc Trop Med Hyg; 2012 Aug; 106(8):484-8. PubMed ID: 22703696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungistatic and fungicidal effects of amphotericin B, ketoconazole and fluconazole (UK 49,858) against histoplasma capsulatum in vitro and in vivo.
    Polak A; Dixon DM
    Mykosen; 1987 Apr; 30(4):186-94. PubMed ID: 3035371
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis.
    Pappagianis D; Zimmer BL; Theodoropoulos G; Plempel M; Hector RF
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1132-8. PubMed ID: 2393272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fluconazole with amphotericin B in treatment of histoplasmosis in normal and immunosuppressed mice.
    Kobayashi GS; Travis SJ; Medoff G
    Rev Infect Dis; 1990; 12 Suppl 3():S291-3. PubMed ID: 2330487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil.
    Brilhante RSN; Guedes GMM; Silva MLQD; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
    Int J Antimicrob Agents; 2018 Aug; 52(2):272-277. PubMed ID: 29592837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice.
    Connolly P; Wheat LJ; Schnizlein-Bick C; Durkin M; Kohler S; Smedema M; Goldberg J; Brizendine E; Loebenberg D
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2604-8. PubMed ID: 10991831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection.
    Haynes RR; Connolly PA; Durkin MM; LeMonte AM; Smedema ML; Brizendine E; Wheat LJ
    J Infect Dis; 2002 Jun; 185(12):1830-2. PubMed ID: 12085335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of murine histoplasmosis with UK 49,858 (fluconazole).
    Graybill JR; Palou E; Ahrens J
    Am Rev Respir Dis; 1986 Oct; 134(4):768-70. PubMed ID: 3021035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.
    Sugar AM; Liu XP
    Antimicrob Agents Chemother; 1996 May; 40(5):1314-6. PubMed ID: 8723494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro sensitivity of Histoplasma capsulatum var. capsulatum to amphotericin B, ketoconazole, itroconazole and fluconazole].
    Andreu CM; León AM; Medina YE; Machín GM; Lancha MR; Zaragozí MT
    Rev Cubana Med Trop; 2003; 55(2):76-82. PubMed ID: 15849960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of sordarins in murine histoplasmosis.
    Graybill JR; Najvar L; Fothergill A; Bocanegra R; de las Heras FG
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1716-8. PubMed ID: 10390228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.
    Clemons KV; Homola ME; Stevens DA
    Antimicrob Agents Chemother; 1995 May; 39(5):1169-72. PubMed ID: 7625808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the triazole D0870 in a murine model of systemic histoplasmosis.
    Clemons KV; Stevens DA
    Antimicrob Agents Chemother; 1995 Mar; 39(3):778-80. PubMed ID: 7793893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304.
    Defaveri J; Salazar MH; Rinaldi MG; Graybill JR
    Am Rev Respir Dis; 1990 Sep; 142(3):512-5. PubMed ID: 2202244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole.
    Wheat LJ; Connolly P; Smedema M; Durkin M; Brizendine E; Mann P; Patel R; McNicholas PM; Goldman M
    J Antimicrob Chemother; 2006 Jun; 57(6):1235-9. PubMed ID: 16627592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
    Hata K; Kimura J; Miki H; Toyosawa T; Nakamura T; Katsu K
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2237-42. PubMed ID: 8891121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.